Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial. - Morand EF; Dall'Era M; Sanchez-Guerrero J; Pearson DR; Werth VP; Wenzel J; Roy S; Kleinmond C; Gühring H; Sgouroudi E; Klopp-Schulze L; Moreau F; et al. (Lancet (London, England), 2026)